Ypsomed Holding AG (LON:0QLQ)
London flag London · Delayed Price · Currency is GBP · Price in CHF
348.25
+5.75 (1.68%)
At close: Apr 30, 2025

Ypsomed Holding AG Revenue

Ypsomed Holding AG had revenue of 324.01M CHF in the half year ending September 30, 2024, with 32.66% growth. This brings the company's revenue in the last twelve months to 617.07M, up 21.33% year-over-year. In the fiscal year ending March 31, 2024, Ypsomed Holding AG had annual revenue of 548.46M with 10.25% growth.

Revenue (ttm)
617.07M CHF
Revenue Growth
+21.33%
P/S Ratio
8.10
Revenue / Employee
268.76K CHF
Employees
2,296
Market Cap
4.41B GBP

Revenue Chart

* This company reports financials in CHF.

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024548.46M51.00M10.25%
Mar 31, 2023497.46M32.62M7.02%
Mar 31, 2022464.84M61.19M15.16%
Mar 31, 2021403.66M9.39M2.38%
Mar 31, 2020394.26M-59.50M-13.11%
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Mar 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.38B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Oxford Nanopore Technologies 183.19M
Revenue Rankings